A study from the Swedish dementia registry

Correlation of stroke and dementia with death

 

Soest, The Netherlands (December 14, 2018) – A great number of studies have consistently scrutinized the relation between dementia and stroke, with a multiple fold increase in the risk factor for death. Swedish scientists at Karolinska Institute, conducted a retrospective survey using patient data in the Swedish Dementia Registry to figure out such relationships through direct association of dementia and ischemic stroke (IS) deaths. Additionally, other recorded evidences e.g. cause of death, any co-occurring disease as well as use of different drugs had been obtained from Swedish nationwide health registers.

Criteria fixed by Dr. Subic et al. to measure the accurate death count attributable to stroke diagnoses included various sub-divisions; 1) stroke as a death cause with registered data in Swedish Stroke Register (Riksstroke) and 2) data correlated to diagnosis of dementia, with comparative analysis concerning patients dying from IS and registered in Riksstroke, patients dying from IS without being registered in Riksstroke and those dying from other causes.

The accurate percentages of death from years 2007-2014 have been calculated. Interestingly, out of the 49823 patients with dementia diagnosis (in primary care or specialist clinics), the death rate in 2014 was recorded to be 28.4%, indicating 8.3% reports of Ischemic Stroke in their death certificates and only 38.9% had been registered in Riksstroke. Of patients who died of IS, there were additionally 153 patients who had a Riksstroke registration more than a year preceding death, totaling 612 patients with a confirmed IS or 52% of those with IS mentioned on their death certificates. Additionally, the statistics indicated that 56.0% of patients died from IS and registered in Riksstroke died in hospital compared to 16.8% patients who died from IS without being registered in Riksstroke, and 25.1% who died from other causes.

Death cause in IS patients was documented as vascular dementia whilst other deaths had diagnosis of Alzheimer’s dementia. Another significant diagnosis for IS patients’ deaths was the consumption of cardiovascular medications. Conversely, no difference had been observed in the use of antidepressants, anxiolytics, antipsychotics, acetylcholinesterase inhibitors, hypnotics and memantine drugs amongst the groups.

A relatively high number of patients died from IS (as per death certificate record), but no data had been listed in Riksstroke in the year before death. The current study, thus, generates significant information to question the accuracy of death certificate stroke diagnoses, for deaths reported outside Swedish hospitals, in particular. The authors conclude that these results are concerning for health monitoring processes in the region as mortality data is an important metric for guiding heath care programs and framing adequate public health policies.

  • This article by Dr. Ana Subic et al. is published in Current Alzheimer Research, Volume 15 , Issue 14 , 2018
  • This article is Open Access. To obtain the article please visit http://www.eurekaselect.com/165854

 


Bentham Science Publishers, 14.12.2018 (tB).

Schlagwörter: , ,

MEDICAL NEWS

Inadequate sequencing of SARS-CoV-2 variants impedes global response to COVID-19
New meta-analysis finds cannabis may be linked to development of…
New guidance on how to diagnosis and manage osteoporosis in…
Starting the day off with chocolate could have unexpected benefits
Better mental health supports for nurses needed, study finds

SCHMERZ PAINCARE

Versorgung verbessern: Deutsche Gesellschaft für Schmerzmedizin fordert die Einführung des…
Pflegeexpertise im Fokus: Schmerzmanagement nach Operationen
Versorgung verbessern: Bundesweite Initiative der Deutschen Gesellschaft für Schmerzmedizin zu…
Jedes vierte Kind wünscht bessere Schmerzbehandlung
Lebensqualität von Patienten in der dauerhaften Schmerztherapie mit Opioiden verbessern

DIABETES

„Wissen was bei Diabetes zählt: Gesünder unter 7 PLUS“ gibt…
Toujeo® bei Typ-1-Diabetes: Weniger schwere Hypoglykämien und weniger Ketoazidosen 
Bundestag berät über DMP Adipositas: DDG begrüßt dies als Teil…
Mit der Smartwatch Insulinbildung steuern
Verbände fordern bessere Ausbildung und Honorierung von Pflegekräften für Menschen…

ERNÄHRUNG

Wie eine Diät die Darmflora beeinflusst: Krankenhauskeim spielt wichtige Rolle…
DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?
Regelmässiger Koffeinkonsum verändert Hirnstrukturen
Corona-Erkrankung: Fehl- und Mangelernährung sind unterschätze Risikofaktoren

ONKOLOGIE

Anti-Myelom-Therapie mit zusätzlich Daratumumab noch effektiver
Positive Ergebnisse beim fortgeschrittenen Prostatakarzinom: Phase-III-Studie zur Radioligandentherapie mit 177Lu-PSMA-617
Lymphom-News vom EHA2021 Virtual. Alle Berichte sind nun online verfügbar!
Deutsch-dänisches Interreg-Projekt: Grenzübergreifende Fortbildungskurse in der onkologischen Pflege
Sotorasib: Neues Medikament macht Lungenkrebs-Patienten Hoffnung

MULTIPLE SKLEROSE

NMOSD-Erkrankungen: Zulassung von Satralizumab zur Behandlung von Jugendlichen und Erwachsenen
Verzögerte Verfügbarkeit von Ofatumumab (Kesimpta®)
Neuer Biomarker bei Multipler Sklerose ermöglicht frühe Risikoeinschätzung und gezielte…
Multiple Sklerose beginnt oft lange vor der Diagnose
Goldstandard für Versorgung bei Multipler Sklerose

PARKINSON

Meilenstein in der Parkinson-Frühdiagnose
Parkinson-Erkrankte besonders stark von Covid-19 betroffen
Gangstörungen durch Kleinhirnschädigung beim atypischen Parkinson-Syndrom
Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…
Gemeinsam gegen Parkinson: bessere Therapie durch multidisziplinäre Versorgung